<http://schema.org/potentialAction>
_:b1
<http://www.genengnews.com/keywordsandtools/email/gen-news-highlights/phase-iii-study-shows-exelixis-cabozantinib-nearly-triples-pfs-in-metastatic-medullary-thyroid-cancer/27392/>